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Abstract: Corneal cryopreservation can partially solve the worldwide concern regarding donor
cornea shortage for keratoplasties. In this study, human corneas were cryopreserved using two
standard cryopreservation protocols that are employed in the Tissue Bank of the Teresa Herrera
Hospital (Spain) to store corneas for tectonic keratoplasties (TK protocol) and aortic valves (AV
protocol), and two vitrification protocols, VS55 and DP6. Endothelial viability and general corneal
state were evaluated to determine the protocol that provides the best results. The potential corneal
cryopreservation protocol was studied in detail taking into consideration some cryopreservation-
related variables and the endothelial integrity and stroma arrangement of the resulting cryopreserved
corneas. TK corneas showed mostly viable endothelial cells, while the others showed few (AV)
or none (DP6 and VS55). The corneal structure was well maintained in TK and AV corneas. TK
corneas showed endothelial acellular areas surrounded by injured cells and a normal-like stromal
fiber arrangement. Cryoprotectant solutions of the TK protocol presented an increasing osmolality
and a physiological pH value. Cooling temperature rate of TK protocol was of 1 ◦C/min to −40 ◦C
and 3 ◦C/min to −120 ◦C, and almost all of dimethyl sulfoxide left the tissue after washing. Future
studies should be done changing cryopreservation-related variables of the TK protocol to store
corneas of optical grade.
Keywords: corneal cryopreservation; cryoprotective agent; corneal endothelium; corneal storage;
corneal transplantation; DMSO
1. Introduction
The current corneal storage methods for keratoplasty only guarantee one month of
optimal tissue preservation. Those are hypothermic and organ culture storage [1,2]. The
storage time limitation and the increasing worldwide scarcity of donor corneas should
encourage us to find a long-term alternative for viable corneal storage. This alternative
would be provided by cryopreservation [2,3].
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During the past decades, many corneal cryopreservation protocols were tested, partic-
ularly after the publication of the promising results of Capella et al. [4] and O’Neill et al. [5].
Based specially on the protocol of Capella et al., who used dimethyl sulfoxide (DMSO)
as the main cryoprotective agent (CPA), several research groups analyzed some variables
related to the corneal cryopreservation procedure and the corneal state after cryopreser-
vation [6]. Afterwards, other cryopreservation parameters were tested, like different
combinations and concentrations of CPAs in different vehicle solutions [7,8], different
methods for CPA addition and removal and different cooling and warming rates, all to
try to avoid cryoinjuries in corneas [9,10]. In that context, corneal vitrification protocols
were designed [7,11–13]. This type of cryopreservation was considered the most appro-
priate if a viable tissue storage is desired, like corneas, cartilage, or aortic valves [14,15].
Theoretically, vitrification avoids ice formation inside cells and in tissue matrix using a
high concentration of CPAs and superfast cooling and warming rates [16,17]. Standard
cryopreservation only allows to control and minimizes ice crystal formation using a minor
concentration of CPAs to avoid cytotoxicity when temperatures decrease or increase during
the process [11,16,18,19].
In corneal cryopreservation, the evaluation of protocols is usually focused on the state
of corneal endothelium. Endothelium is the main corneal layer responsible for maintaining
stromal dehydration and, therefore, corneal transparency. This cell monolayer acts as a
pump-leaky barrier that regulates the transport of solutes and water between aqueous
humor and stroma [20]. As the endothelium has a limited capacity of regeneration [21], the
extreme loss of endothelial cells (ECs) and/or of their functionality would be inadmissible
if a viable cornea of optical grade is required. Because of this reason, the state of endothe-
lium after cryopreservation is the best indicator of a successful corneal cryopreservation
protocol [18].
Despite all attempts, any cryopreservation protocol for human corneas has not pro-
vided a tissue with all the endothelial qualities required to ensure a valid cornea [1]. Nor-
mally, corneas after cryopreservation showed a disrupted endothelial integrity [3,18,22],
low EC viability, or an impaired endothelial function [23,24]. Furthermore, although hu-
man cryopreserved corneas have been used in penetrant keratoplasties, the high variability
of clinical results pushed the cryopreservation technique to the background. Cryopreserva-
tion, as of now, is recommended only in emergencies for tectonic keratoplasty [25,26].
In this study, we evaluated the results of four cryopreservation protocols to store
viable human corneas. Two of the protocols are standard cryopreservation procedures
with the same controlled freezing temperature. Both are used in the Tissue Bank of the
Teresa Herrera Hospital (Spain) to cryopreserve corneas for tectonic keratoplasties (TK
protocol) and to cryopreserve aortic valves (AV protocol). The other two are experimental
protocols of vitrification. VS55 was tested before with other small tissues that require
viability [14,15], and DP6 is a version of VS55 without the CA formamide. We evaluated
the endothelial viability immediately after thawing as well as the general corneal structure
integrity. Then, we analyzed in detail the cryopreserved tissue that showed the best
viability and histological results and the cryopreservation-related variables of the protocol.
This way, we will have a starting point to improve the cryopreservation protocol to obtain
a cryopreserved cornea of optical grade.
2. Results
2.1. Endothelial cell Viability of Cryopreserved Corneas
EC viability was analyzed qualitatively. The endothelia of TK-cryopreserved corneas
showed mostly attached viable cells with intact cell membranes and enzymatic activity
(Figure 1A), while in AV-cryopreserved corneas, endothelial cells remained attached but
were mostly non-viable (Figure 1B). Some viable cells showed non-stained black vesicles
on the cytoplasm. With respect to vitrification protocols, non-viable cells in the endothelia
of VS55- and DP6-cryopreserved corneas were observed, although stained nuclei revealed
that cells remained attached to Descemet’s membrane (Figure 1C,D).
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Nuclei of viable and non-viable cells are stained by Hoechst (blue). The cytoplasm of viable cells with intact cell mem-
branes and enzymatic activity contains calcein AM (green), while the cytoplasm of non-viable cells with damaged cell 
membrane and/or non-enzymatic activity shows a green dotted cytoplasm or no signal of calcein AM; white arrows: small 
acellular areas; *: large strip-like acellular areas. Scale: 100 μm. 
2.2. General Corneal Structural Integrity 
Masson’s trichrome staining showed disrupted endothelia in all thawed cryo-
preserved corneas but in different ways. Only TK corneas and AV corneas showed cell 
debris but not a complete cell monolayer attached to Descemet’s membrane, with few 
intact ECs (Figure 2A,C). In DP6 and VS55 corneas, there was no endothelium in almost 
all cornea slides but some minimal cell debris at the periphery. 
With respect to the stroma, a disruption in the collagen matrix was visible in the pos-
terior (endothelial) part in TK-, DP6-, and VS55-cryopreserved corneas, being minimal in 
the anterior (epithelial) part, probably due to the quick uptake of water during the cryo-
preservation process. The stroma of TK- and AV-cryopreserved corneas were similar to 
the hypothermic-storage corneal control (not shown). 
Figure 1. Pictures of corneal endothelia of thawed cryopreserved corneas after CPA removal and calcein AM assay.
Endothelium of thawed cryopreserved cornea of (A) TK protocol, (B) AV protocol, (C) VS55 protocol, and (D) DP6 protocol.
Nuclei of viable and non-viable cells are stained by Hoechst (blue). The cytoplasm of viable cells with intact cell membranes
and enzymatic activity contains calcein AM (green), while the cytoplasm of non-viable cells with damaged cell membrane
and/or non-enzymatic activity shows a green dotted cytoplasm or no signal of calcein AM; white arrows: small acellular
areas; *: large strip-like acellular areas. Scale: 100 µm.
In all cryopreserved endothelia, even in the fresh control (data not shown), the cell
monolayer was disrupted, showing acellular areas on Descemet’s membrane and, therefore,
decreasing the endothelial cell density. In cryopreserved corneas, those areas were numer-
ous and of different shapes and sizes, for example, long strips or small spaces without any
cell (Figure 1), while in the fresh control, there were very few small acellular areas that
possibly indicated the loss of one cell on the highly viable endothelium.
2.2. General Corneal St uctural Integrity
Masson’s trichrome staining showed disrupted endothelia in all thawed cryopreserved
corneas but in different ways. Only T corneas and AV corneas showed cell debris but
not a complete cell monolayer attached to Descemet’s membrane, with few intact ECs
(Figure 2A,C). In DP6 and VS55 corneas, there was no endothelium in almost all cornea
slides but some minimal cell debris at the periphery.
With respect to the stroma, a disruption in the collagen matrix was visible in the
posterior (endothelial) part in TK-, DP6-, and VS55-cryopreserved corneas, being minimal
in the anterior (epithelial) part, probably due to the quick uptake of water during the
cryopreservation process. The stroma of TK- and AV-cryopreserved corneas were similar
to the hypothermic-storage corneal control (not shown).
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collagen fibers in P1-cryopreserved corneas (D) (scale: 1 μm), with the details visible in a transversal cut of the collagen 
fibers (E) (scale: 200 nm). 
Epithelia of TK- and AV-cryopreserved corneas suffered flattening and desquama-
tion, maintaining from two to three layers in the central part of the cornea (Figure 2A,B). 
In the case of TK cornea, epithelium remained attached in all extensions, while in the case 
of AV-cryopreserved cornea, a separation between endothelia and Bowman’s layers ex-
isted. The endothelia of VS55- and DP6-cryopreserved corneas were not visible in the cen-
tral part of the corneas, but at the periphery, close to the trabecular meshwork. 
As the TK protocol showed a higher number of viable cells and a more similar pre-
served cornea structure with respect to the control cornea, we discarded the other proto-
cols for subsequent analysis. 
2.3. Stromal Collagen Distribution of TK-Cryopreserved Corneas 
TK-cryopreserved corneas presented a stroma with a regular collagen arrangement 
(Figure 2D), without the presence of possible breaks due to ice crystals. The distance 
among fibers in the two thawed corneas was 23.2 ± 7.7 nm and 27.1 ± 7.9 nm (Figure 2E), 
which was significatively superior to the interfibrillar distance in fresh cornea (19.4 ± 6.1 
nm; p = 0.00). However, TK-cryopreserved corneas showed relative transparency (Figure 
3A), with some exceptions (Figure 3B). 
Figure 2. Transversal cuts of TK-cryopreserved corneas stained with Masson’s trichrome. All corneal layers are visible (A)
(scale: 100 µm). Details of the epithelium (B) and the endothelium (C) (scale: 50 µm). TEM image of the banded pattern of
collagen fibers in P1-cryopreserved corneas (D) (scale: 1 µm), with the details visible in a transversal cut of the collagen
fibers (E) (scale: 200 nm).
Epithelia of TK- and AV-cryopreserved corneas suffered flattening and desquamation,
maintaining from two to three layers in the central part of the cornea (Figure 2A,B). In
the case of TK cornea, epithelium remained attached in all extensions, while in the case of
AV-cryopreserved cornea, a separation between endothelia and Bowman’s layers existed.
The endothelia of VS55- and DP6-cryopreserved corneas were not visible in the central part
of the corneas, but at the periphery, close to the trabecular meshwork.
As the TK protocol showed a higher nu ber of viable cells and a ore si ilar pre-
served cornea structure with respect to the control cornea, we discarded the other protocols
for subsequent analysis.
t l l
2D), without he pres nce of possible r aks due to ice crystals. The distance among
fibers in the two thawed corn as was 23.2 ± 7.7 nm and 27.1 ± 7.9 nm (Figure 2E), which
as significatively superior to the interfibrillar distance in fr sh cornea (19.4 ± 6.1 nm;
p = 0.00). However, TK-cryoprese ved corneas showed relative transp rency (Figure 3A),
with some exc ptions (Figure 3B).
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varied among endothelia. These areas were usually localized at the periphery and/or in 
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spaces (Figure 3C), or small spots (Figure 3E). The remaining attached cells frequently 
showed some blue-stained nuclei, indicating cell permeability (Figure 3C–E). In some 
cases, these cells were observed in all the extensions of the endothelium and in groups; 
however, they were mainly present surrounding large or small bare acellular areas (Figure 
3E) or on Descemet’s membrane folds (Figure 3D). 
2.5. Parameters of TK-Cryoprotectant Solutions 
The osmolalities of TK cryoprotectant solutions (CSs) increased with the increasing 
of DMSO concentrations. The osmolalities of CS1-TK, CS2-TK, and CS3-TK were 639.0 ± 
1.5, 1026.7 ± 4.2, and 1647.0 ± 7.2 mOsm/kg, respectively, the last one being hyperosmotic 
with respect to the albumin washing solution (274.0 ± 1.0 mOsm/kg; p = 0.01). The pH of 
all solutions was maintained at the physiologic level of 7.3 (21 °C). 
2.6. Sample Cooling Profile of TK protocol 
The sample cooling profile of protocol TK is represented in Figure 4 and the varia-
tions in cooling rates in each segment of the programmed profile are displayed in Table 1. 
In brief, corneal samples were cooled slowly, reaching 4.2 °C. In that moment, the shock 
cooling forced ice nucleation with the consequent liberation of latent heat of fusion, which 
Figure 3. Vital stain in two TK-thawed cryopreserved corneas. The first cornea (A) shows a relative transparency that
enables one to see the bold dots, while the second cornea (B) is more translucid and shows an endothelium with large strips,
big amorphous spaces (black *), and a high amount of non-viable cells (blue nuclei) (C). The endothelium of a cornea (A)
showing folds with non-viable cells on them (black arrow) (D) (scale: 1.5 mm), as well as small, acellular areas (white *)
surrounded by non-viable cells (white arrow) (E) (scale: 200 µm).
2.4. Endothelial Integrity of TK-Cryopreserved Corneas
Vital stain allowed observing of acellular areas in Descemet’s membrane stained in
red in the endothelia of TK-cryopreserved corneas. The size and quantity of acellular areas
varied among endothelia. These areas were usually localized at the periphery and/or in
the central part of the endothelium, similar to large stripes (Figure 3C,D), big amorphous
spaces (Figure 3C), or small spots (Figure 3E). The remaining attached cells frequently
showed some blue-stained nuclei, indicating cell permeability (Figure 3C–E). In some cases,
these cells were observed in all the extensions of the endothelium and in groups; however,
they were mainly present surrounding large or small bare acellular areas (Figure 3E) or on
Descemet’s membrane folds (Figure 3D).
2.5. Parameters of TK-Cryoprotectant Solutions
The osmolalities of TK cryoprotectant solutions (CSs) increased with the increasing of
DMSO concentrations. The osmolalities of CS1-TK, CS2-TK, and CS3-TK were 639.0 ± 1.5,
1026.7 ± 4.2, and 1647.0 ± 7.2 mOsm/kg, respectively, the last one being hyperosmotic
with respect to the albumin washing solution (274.0 ± 1.0 mOsm/kg; p = 0.01). The pH of
all solutions was maintained at the physiologic level of 7.3 (21 ◦C).
. . a le ooli rofile of rotocol
l li g profile of protocol TK is repres nted in Figure 4 and the variations
in cooling rates in each segm nt of he programmed profile ar displayed in Table 1. In
brief, corneal samples wer co led slowly, reaching 4.2 ◦C. In that t,
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cooling forced ice nucleation with the consequent liberation of latent heat of fusion, which
was partially counteracted by an abrupt decrease in the temperature chamber. The sample
temperature was elevated from −7.9 to −2.7 ◦C in 27 s, achieving the equilibrium freez-
ing point at −2.6 ◦C. A plateau at approximately −2.7 and −2.6 ◦C was maintained for
70.2 s, followed by a decrease in temperature. The velocity of the sample cooling rate
increased progressively from –1.09 ◦C/min when the sample temperature was at −6 ◦C, to
−3.80 ◦C/min when sample was at −78 ◦C.
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Figure 4. Graphic representation of temperature (y-axis) versus time (x-axis) during the cooling process of TK-cryopreserved
corneas. In black, the temperature program; in yellow, the recorded temperature in the freezer chamber; in orange, the
recorded temperature of samples.
Table 1. Sample cooling rate of each segment of the freezing program for the TK protocol. Although
the temperature sample presents a fluctuation when nucleation is caused with a cooling shock, the
temperature sample descends at a rate of approximately 1 ◦C/min to −38.8 ◦C and 3 ◦C/min to
−116.6 ◦C.
Cooling Rate (◦C/min) Duration (min) Final Temperature (◦C)
Seg 1 + 2 −0.05 15 4.2
Seg 3 −1.15 8 −5.0
Seg 4 −2.76 1 −7.7
Seg 5 +5.20 1 −2.7
Seg 6 −0.31 1 −3.0
Seg 7 −1.46 2 −6.0
Seg 8 −1.09 30 −38.8
Seg 9 −2.62 15 −78.0
Seg 10 −3.80 12 −116.6
2.7. DMSO Removal of TK-Cryopreserved Corneas
The DMSO concentration in unwashed samples was 0.83 ± 0.08 M. A significant
reduction of DMSO concentration was observed after the first wash (0.31 ± 0.05 M) and
after the second wash (0.14 ± 0.01 M) but not after the third wash (0.10 ± 0.02 M) (Figure 5).
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In this study, we evaluated four corneal cryopreservation protocols attending specif-
ically to corneal endothelial state, as endothelium is the major responsible for corneal 
transparency and the first indicator of a successful cryopreservation protocol [18]. 
Results show that all cryopreservation protocols are far from being usable in clinic, 
mainly due to endothelial disruption, which affects its functionality. However, TK-cryo-
preserved corneas are those that clearly offer a major amount of attached viable cells, so 
we recorded the cryopreservation-related variables of the TK-cryopreservation protocol. 
This protocol was selected as the potential protocol that could be improved to store valid 
functional corneas for keratoplasties. 
Cryopreservation-related variables can explain partially the obtained endothelial vi-
ability and integrity results. These variables are the composition of CSs, the methods to 
add and remove CPAs, and the cooling and warming rates. Among cryoinjuries that cells 
can suffer, cell toxicity, osmotic stress, and mechanical injure by ice crystals are the most 
important. 
CSs usually contain multimolar concentrations of CPAs that can be toxic for cells 
[13,17]. A low temperature and progressive contact with increasing or decreasing concen-
trations of CPAs in the addition or removal step should be considered in any cryopreser-
vation protocol to reduce cytotoxicity [17]. 
Some CPAs, such as DMSO, proved to be low in cytotoxicity to ECs at low tempera-
tures. Thus, DMSO was present in numerous standard cryopreservation and vitrification 
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ter and DMSO concentra ions; ppm: particles per million.
3. Discussion
In this study, we evaluated four corneal cryopreservation protocols attending specif-
ically to corneal endothelial state, as endothelium is the major responsible for corneal
transparency and the first indicator of a successful cryopreservation protocol [18].
Results show that all cryopreservation protocols are far from being usable in clinic,
mainly due to endothelial disruption, which affects its functionality. However, TK-
cryopres rved corneas re those that clearly o r a major am unt of attach d viable
cells, so we recorded t e cryopreservation-r lated variables of the TK-cryopreservation
protocol. This protocol was selected as the potential protocol that could be improved to
store valid functional corneas for keratoplasties.
Cryopreservation-related variables can explain partially the obtained endothelial
viability and integrity results. These variables are the composition of CSs, the methods
to add and remove CPAs, and the cooling and warming rates. Among cryoinjuries that
cells can suffer, cell toxicity, osmotic stress, and mechanical injure by ice crystals are the
most important.
CSs usually con ain multimolar concentrations of CPAs that can be toxi for cells [13,17].
A low temperature and progressive contact with increasing or decreasing concentrations of
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CPAs in the addition or removal step should be considered in any cryopreservation protocol
to reduce cytotoxicity [17].
Some CPAs, such as DMSO, proved to be low in cytotoxicity to ECs at low tempera-
tures. Thus, DMSO was present in numerous standard cryopreservation and vitrification
protocols from the beginning of corneal cryopreservation [3,4,18,27,28]. In TK and AV pro-
tocols, DMSO was added to corneas in cold CSs. Furthermore, the last CS of both protocols
contains 2 M DMSO, a concentration that was demonstrated to be tolerated by ECs [8]. It
is probable that cytotoxicity does not affect cells in the tested standard cryopreservation
protocols, unlike vitrification protocols, where the elevated molarity of CPAs could be
toxic for ECs. CPA addition in both vitrification protocols took place using a drop-by-drop
technique, which could be too slow and in consequence, corneal cells would stay in contact
with toxic concentrations of CPAs for a long time in a not-cold-enough CS. It was described
that low temperatures or even subzero temperatures during CPA addition minimizes the
cytotoxicity in a vitrification protocol [13].
For the four protocols, cell osmotic stress during addition and removal of CPAs could
contribute to the loss of membrane integrity and/or of the enzymatic activity of ECs.
Cells try to compensate any osmotic imbalance with medium. Abrupt osmolality changes
can injure cells, causing extreme deturgescence or turgescence, or non-controlled ionic
imbalance that can affect the functionality of the cellular system [17].
In our study, the non-stained vesicles in ECs after the calcein AM assay may be equiv-
alent to those described by Wusteman et al. [28]. In that article, the authors hypothesized
that the non-stained vesicles that they observed in the endothelia, just after DMSO addition,
could be a cell response to osmotic and pH stress and would reflect the blebbing process
that normally occurs before apoptosis.
Osmotic stress during cryopreservation can have several causes. The ionic composition
of the vehicle solution of CSs is one of them. Some authors took this parameter into
consideration, using ionic solutions that helped diminish the osmotic stress of EC in cold
environments [10,13,27–29]. These solutions provided better results than a commercial
tissue organ medium, similar to those that we employed in TK and AV protocols or those
that other authors used in their corneal cryopreservation protocols [3,5,6,18,29].
The addition and removal steps are also critical at the cell osmotic level. It was reported
that a gradual addition and removal of CPAs produces better results of endothelial cell
viability as they help control cell osmotic stress [8,10,17]. Taking the example of the TK
protocol, the differences among the increasing osmolalities of the consecutive CSs where
corneas were embedded and the significative difference between the osmolalities of the
third CS and the washing solution could not be osmotically well tolerated by ECs. For any
of the four protocols, an increase in the number of CS solutions to reduce the osmolality
leaps among them would lead to less osmotic stress in cells before freezing. In addition,
for washing solutions, the same composition of CSs but with decreasing concentrations of
CPAs would prevent a possible stress shock of ECs during CPA removal.
Toxic CPA removal is an important factor to avoid cell toxicity when cryopreserved
corneas are at room temperature and if the cryopreserved cornea was transplanted, to
prevent the toxic CPAs from passing to the receptor fluids or tissues. Thus, with NMR
technology, we could measure the concentration of DMSO in TK-cryopreserved corneas
and we observed that after washing, a concentration of only 0.1 M stayed in the tissue.
Ideally, DMSO and any toxic CPAs should be reduced as much as possible before cell,
tissue, or organ transplantation [30,31].
With respect to the cooling and warming rates, unadjusted speeds can lead to ex-
tracellular and intercellular ice formation that can mechanically injure tissue and cells.
Uncontrolled intracellular ice formation could be responsible for mechanical injuries in
the corneal endothelium [13,17]. The corneal endothelium is a monolayer of cells joined
via GAP junctions. If intracellular ice is formed, these ice crystals can expand through
GAP junctions, injure adjacent cells, and cause mechanical damages in cell membranes
and the disruption of clusters of cells [32]. This would be able to justify the presence of the
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big acellular areas and the large acellular strips in all cryopreserved corneal endothelia
because cells may be disrupted in groups and detached. In addition, ice crystals could
be responsible for the loss of membrane integrity in the remaining ECs of VS55- and
DP6- cryopreserved corneas. In these two cases, the non-viable ECs could be the result
of devitrification, that is, the formation of ice crystals during warming if this is not done
quick enough. Devitrification together with toxic CPA concentrations was described as
one of the biggest challenges of vitrification [12,23]. To the best of our knowledge, only
Armitage et al. [13] have succeeded in vitrifying rabbit corneas that retained functionality
without devitrification.
It is mentioned that in standard cryopreservation, cooling rates of less than 1 ◦C/min
and rates of 20 ◦C/min for warming can provide endothelial integrity and functionality [10].
Other cryopreservation protocols failed using temperature rates of 1 ◦C/min or superior,
resulting in a corneal endothelium with acellular areas similar to those described in this
study [18,33]. The cooling rate of TK protocol (and probably of AV protocol, as the cooling
program was the same) was of approximately −1 ◦C/min to −40 ◦C and −3 ◦C/min to
−120 ◦C. For this protocol, it would be necessary to design a cooling ramp that allows a
slow decrease in the sample temperature to −80 ◦C.
Focusing on the general state of the cornea, a notable result that we observed in TK-
cryopreserved corneas was the relative transparency, even when the interfibrillar distance
in the transparent hypothermic-stored cornea was lower. Corneal transparency is related
to the collagen fibers’ disposition in stromal lamellae and the interfibrillar distance among
them [34]. The albumin of the wash solution could help to maintain the transparency, play-
ing the role of an osmotic buffer to prevent stromal swelling, the way sucrose or mannitol
did in other published corneal cryopreservation protocols [10,13,27,28]. Holes visualized in
Masson’s trichrome may be the result of Masson’s own histological technique but also may
be the result of corneal swelling changes during cryopreservation that separate lamellas.
Despite all this, we should consider that although cryopreserved corneal tissue is
damaged during the cryopreservation process of cornea, injuries can start before cryop-
reservation, i.e., after donor death and during hypothermic storage.
After donor death, several anatomic and physiological changes occur in corneas.
Napoli et al. detected in non-enucleated corneas, stromal thickness changes, separation
of collagen lamellae, the flattened of epithelium due to the loss of tear films and water
evaporation, or the failure of endothelium due to hypoxia [35–37]. This research group
could detect these postmortem physiological changes in a non-invasive manner, using the
portable optical coherence tomography (OCT) system. OCT is an useful technique to study
the cornea surface and tear film [38–40] and to detect alterations caused by pathologies
such as keratoconus or dry eye syndrome that can affect the corneal structure [41]. Corneas
employed in this study were enucleated in the first 24 h postmortem, and although no
corneal alterations were registered before enucleation, we should assume that some damage
could be already present in the hypothermic stored samples.
Hypothermic conditions modify the corneal structure, and the corneas employed in
this study were stored for days until being cryopreserved. Hypothermic storage usually
creates folds in Descemet’s membrane [42]. These folds and the possible endothelium
damage before enucleation could directly affect the endothelial results. The endothelium
could be more susceptible to posterior cryoinjuries, mainly ECs that lie on Descemet’s folds,
if not the whole endothelium. Hence, ECs would more easily detach from Descemet’s
membrane or would turn into non-viable cells after a cryopreservation process.
A clear limitation of this study was the low number of samples and the interindividual
variability, which is a common limitation in other studies of human corneal cryopreser-
vation [18]. Another limitation of this study was the employed histological techniques,
which only provides a first photograph of the cryopreserved corneas after thawing. After
cryopreservation, it is necessary to perform experiments of corneal permeation to study
the endothelial functionality [10,13,23,28] and to understand what can occur if it is trans-
planted. That way, we can see if the initially damaged or apparently intact ECs would be
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able to restore their functionality or directly suffer apoptosis and detach, causing stroma
edema. In addition, and despite the current scarcity of donor corneas, it would be desirable
to increment the number of samples of the study, homogenize the characteristics of samples,
and make a complete study of corneas before enucleation and just before cryopreservation,
using non-invasive techniques, such as OCT, and equipment such as the slip lamp and the
specular microscope.
Definitively, none of the cryopreservation protocols were valid for being implemented
in clinic. However, this study allows us to detect the drawbacks of the TK protocol. The
cryopreservation-related variables of the current protocol will provide us a start point
to improve it and to obtain a corneal cryopreservation protocol for storing valid corneas
for keratoplasties.
4. Materials and Methods
4.1. Corneal Samples
The present study was approved by the Ethics Committee of Research from A Coruña-
Ferrol, Spain (registration code: 2017/594). Cadaveric donor human corneas were obtained
from corneas that were discarded by the Tissue Bank of Teresa Herrera Hospital (Galicia,
Spain). We included all the corneas that were not valid for use in clinic except those that
were discarded due to donor infection, with an ECD below 1500 cell/mm2, endothelial
pathology, or alteration in the endothelium. The main reasons of corneal discard were arcus
senilis, an ECD inferior to 2000 cell/mm2, infiltrates, leukoma, and the non-transplantation
of a valid cornea after 7 days in hypothermic storage. Corneal samples were stored from 5
to 15 days in Eusol-C media (AlchimiA, Padova, Italia) at 4 ◦C until their use. The average
donor age was 67 ± 6 years.
4.2. Cryoprotectant Solutions
Cryoprotectant solutions (CSs) of the TK protocol (CS-TK) consisted of a mixture
of Medium 199 1X (M199; Gibco, Madrid, Spain), a perfusion solution of 20% human
albumin (Albutein 20%; Grifols, Barcelona, Spain), and dimethyl sulfoxide (DMSO; Sigma,
Madrid, Spain); for AV protocol, they consisted of M199 and DMSO; for VS55 protocol,
they consisted of Euro-Collins 5X [15], propylene glycol (Sigma, Madrid, Spain), DMSO,
formamide (Sigma, Madrid Spain), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
(HEPES; Panreac, Barcelona, Spain), and distilled water; for DP6 protocol, they included
Euro-Collins 5X, propylene glycol, DMSO, and HEPES. The concentrations of the com-
ponents of the CSs are shown in Table 2. The CS were maintained at 4 ◦C for at least 1 h
before use.
Table 2. Component concentrations of cryoprotectant solutions (CSs) of the tested standard cryopreservation protocols
(CPs) of corneas for tectonic keratoplasty (TK) and for aortic valves (AV) and experimental vitrification protocols (VP) VS55
and DP6. Concentrations are expressed in % (v/v), and penetrant cryoprotectants are also expressed in molarity.
CP-TK CP-AV
CS1-TK CS2-TK CS3-TK CS1-AV CS2-AV CS3-AV
DMSO (v/v) 2% (0.3 M) 4% (0.6 M) 7% (1 M) 2% (0.3 M) 4% (0.6 M) 7% (1 M)
20% albumin (v/v) 25% 25% 25% − − −
M199 1X a (v/v) 73% 71% 68% 98% 96% 93%
VP-VS55 VP-DP6
Propylene glycol (v/v) 16.25% (2.2 M) 22.04% (3.0 M)
DMSO (v/v) 22.01% (3.1 M) 21.31% (3.0 M)
Formamide (v/v) 12.31% (3.1 M) −
Euro-Collins 5X (v/v) 20.00% 56.65%
Distilled water (v/v) 29.43% −
HEPES (g) 2.4 g 2.4 g
a M199 1X: Medium 199 1X.
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For each CS of TK protocol, the osmolality was measured in triplicate with a cryoscopic
osmometer (Osmomat 030; Gonotec, Berlin, Germany) and the pH of each solution was
determined using the pH-meter GLP21 (Crison, Castellón, Spain). Statistical analysis
was performed with GraphPad Prisma software using a non-parametric test (Kruskal–
Wallis test) to compare osmolalities among the different solutions, considering significant a
p-value < 0.05. Results were expressed as the mean ± standard deviation.
4.3. Addition of Cryoprotectant Agents and the Cooling Process
Corneas were randomly used for the different cryopreservation protocols. Addition
of CPAs to TK and AV protocols was done gradually. Corneas for TK protocol and corneas
for AV protocol were transferred from the CS with a lower concentration of DMSO to the
next CS with a higher concentration of DMSO, in intervals of 3 min. Finally, they were
transferred into a precooled cryovial with the third CS of TK protocol (CS3-TK) or with the
third CS of AV protocol (CS3-AV) and they were gently shaken on ice (4 ◦C) for 10 min.
Immediately, they were introduced into the freezing chamber of the biological freezer
CM-2010 (Carburos Medica, Barcelona, Spain) precooled at 4 ◦C. The cooling process was
carried out following a temperature program, detailed in Table 3. Cryovials were stored in
the gas phase of liquid nitrogen. For TK protocol, the sample cooling profile was studied
using the report of the cryopreservation process generated by the biological freezer.
Table 3. Segments of the cooling profile used for corneal cryopreservation in TK protocol and
AV protocol.
Seg 1 Seg 2 Seg 3 Seg 4 Seg 5
Final Temperature (◦C) 4.0 0.0 −7.8 −30.0 −40.0
Time (min) 15.0 0.1 8.0 1.0 1.0
Seg 6 Seg 7 Seg 8 Seg 9 Seg 10
Final Temperature (◦C) −15.0 −15.0 −40.0 −80.0 −120.0
Time (min) 1.0 2.0 30.0 15.0 12.0
For VS55 and DP6 protocols, corneas were deposited directly in a precooled cryovial
and respective cold CS were added drop-by-drop. Immediately, the cryovials were frozen
in the liquid phase of a glass with isopentane precooled with liquid nitrogen. After 10 min
in the cold liquid isopentane, the cryovials were transferred to the gas phase of liquid
nitrogen for storage.
4.4. Warming Process and the Removal of Cryoprotectant Agents
For the warming process, cryovials from liquid nitrogen were maintained for 1 min at
room temperature (RT), independently of the protocol used for freezing. Then, the cryovials
were introduced in a water bath at 37 ◦C, without shaking, until complete thawing. For
TK protocol, the corneas were immersed consecutively in three cold wash solutions of 20%
albumin at 5 min intervals. For AV, VS55 and DP6 protocols, cryoprotectant media were
eliminated using progressive dilutions (v/v) with cold saline buffer (Fisiológico B.Braun
0.9%; B. Braun Spain, Barcelona, Spain) (AV) and Euro-Collins 1X (VS55 and DP6), at 5 min
intervals, until the cornea remained only in the washing solution. The thawed corneas
were immediately processed for posterior assays.
4.5. Endothelial Cell Viability Assays
A calcein AM assay (LIVE/DEAD Cell Imaging Kit; Invitrogen, Barcelona, Spain) was
performed on a peeled-off endothelial of two cryopreserved corneas from each protocol,
following the manufacturer’s instructions of the kit and counterstaining with Hoechst
(Sigma, Barcelona, Spain). Endothelia were visualized with the Olympus BX61 microscope
(Olympus España S.A., Barcelona, Spain), coupled with the digital camera Olympus
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DP70 (Olympus España S.A., Barcelona, Spain). The open software FIJI [43] was used for
image merging.
A vital stain with trypan blue and alizarine red was used to determine the endothelial
integrity of 10 TK-cryopreserved corneas. Based on the protocol of Taylor et al. [44], thawed
corneas were rinsed twice with phosphate buffer saline (PBS), stained with 0.2% trypan
blue (Gibco, Madrid, Spain) for 90 s, rinsed twice with PBS, stained with 0.2% alizarin
red (pH 4.2; Panreac, Barcelona, Spain) for 90 s, and rinsed twice before their pictures
were taken with the camera Nikon digital sight DS-Fi2 coupled to the stereoscopy Nikon
SM7 745T.
4.6. Measurement of the DMSO Concentration in Thawed Corneas
The DMSO concentration was measured in TK-cryopreserved corneas after they were
thawed and after each step of the cryoprotectant removal. Proton (1H) nuclear magnetic
resonance (NMR) spectroscopy was used to measure the DMSO concentration, as this
molecule presents a characteristic peak in the NMR spectrum, as described before [9,27,28].
For measurement, three corneas were divided in four pieces after being thawed in the
water bath. One-quarter of each cornea was submerged in a vial with deuterium oxide
(D2O; Sigma, Madrid, Spain). The three remaining quarters were washed with the first
albumin washing solution and after 5 min, one-quarter of each cornea was transferred
to a vial with D2O, and the other two-quarters were transferred to the second albumin
wash. This process was repeated with the remaining quarters of the cornea in the following
washing steps. All pieces of the corneas were left in D2O at room temperature for 24 h to
allow equilibration before they were frozen at −20 ◦C for storage.
To determinate the DMSO concentration, samples were thawed and the bathing D2O
solution was transferred into a glass NMR tube for 1H NMR spectroscopy and analyzed
with the Bruker AVANCE III HD 400.l spectrometer (Bruker, Billerica, MA, USA). Spectra
were acquired after a strong pulse. All the spectra were Fourier transformed with the
software MNova (Mestrelab Research) and automatically phased and integrals of each
water and DMSO peaks were calculated to obtain the absolute value. The concentrations
of DMSO were extrapolated using an experimental curve of the chemical relation between
DMSO and water proton molar ratio for different concentrations of DMSO in milliQ water,
as described before [9]. Statistical analysis was performed with GraphPad Prisma software
using a non-parametric test (Kruskal–Wallis test with Bonferroni correction) to compare
concentrations among the different groups, considering significant a p-value < 0.05. Results
were expressed as the mean ± standard deviation.
4.7. Histomorphological Corneal Assessments
For each protocol, one thawed cornea was fixed in 4% formaldehyde and embedded
in paraffin. Tissue sections were stained with Masson’s trichrome, and images were taken
with the digital camera Olympus DP70 coupled to the Olympus BX61 microscope.
Two thawed TK-cryopreserved corneas and one fresh cornea were prepared for TEM.
The central parts of the corneas were cut into small pieces and prefixed for 30 min at
RT with 1.25% glutaraldehyde (Guimana, Valencia, Spain) and 0.1% paraformaldehyde
(Thermo Fisher Scientific, Madrid, Spain) diluted in cacodylate buffer (1 M; pH 7.4), for
better preservation of stromal collagen fibers [34]. After that, the tissue was fixed for 20 h in
2.5% glutaraldehyde, postfixed with 1% osmium tetroxide, followed by dehydration with
increasing concentrations of acetone solutions, and embedded in resin. Ultrathin sections
were processed and visualized with the JEOL JEM 1010 transmission electron microscope
(JEOL, Tokyo, Japan).
A total of 100 stromal collagen fibers of the posterior stroma were used to measure the
distance among the fibers using the open software FIJI. Statistical analysis was performed
with GraphPad Prisma software using a parametric test (two-tailed t-test) to compare the
mean of the interfibrillar distance of cryopreserved corneas and fresh cornea, considering
significant a p-value < 0.05. Results were expressed as the mean ± standard deviation.
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